Loading clinical trials...
Loading clinical trials...
Randomized Phase II Clinical Trial of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Line Treatment for Metastatic Colorectal Cancer
Conditions
Interventions
Bevacizumab
Oxaliplatin
+2 more
Locations
1
United States
NSABP Operations Center
Pittsburgh, Pennsylvania, United States
Start Date
March 1, 2006
Primary Completion Date
May 1, 2008
Completion Date
June 1, 2010
Last Updated
October 6, 2021
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
NSABP Foundation Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions